The global telehealth market was valued at USD 83.52 billion in 2022 and it is predicted to surpass around USD 719.54 billion by 2032 with a CAGR of 24.03% from 2023 to 2032.
Key Pointers
| Report Coverage | Details |
| Market Size in 2022 | USD 83.52 billion |
| Revenue Forecast by 2032 | USD 719.54 billion |
| Growth rate | CAGR of 24.03% |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Covered | Koninklijke Philips N.V; Siemens Healthineers; Cerner Corp.; GE Healthcare; Medtronic PLC; Teladoc Health Inc; American Well; Doctor on Demand; GlobalMed; MDLive |
The rising penetration of the internet and innovation in smartphones is enabling to address the gaps in the delivery and availing of telehealth services conveniently. Moreover, the demand for telehealth services witnessed tremendous growth over the past year due to the COVID-19 pandemic and the restrictions imposed in order to curb the infection. COVID-19 hindered the delivery of healthcare services which enabled most healthcare facilities to shift from traditional to virtual care methods. Further, the growing need to monitor health and wellness in order to manage chronic diseases virtually is driving the market growth.
Introduction of web-based and cloud-based platforms which deliver virtual care to users are expected to boost the market growth. For instance, in August 2021, CVS and Teladoc partnered to launch CVS Health’s Aetna Virtual Primary Care. Through this partnership, CVS Health will utilize Teladoc’s physician network and providers to deliver virtual care services to patients remotely through video and telephonic consultations, which will reduce the dependency of the patients on in-person consultations and visits.
Increasing prevalence of cancer globally is expected to be a key contributor to the growth of the market. This increasing prevalence is anticipated to strain the healthcare systems, most of which are witnessing a shortage of healthcare professionals such as doctors and nurses; this is anticipated to drive the adoption of the services globally. According to WHO, healthcare facilities are projected to witness a shortage of 15 million healthcare professionals by 2030, this shortage of healthcare professionals is expected to drive the adoption of AI for the treatment and diagnosis of patients. Telehealth helps to deliver healthcare services digitally and virtually to patients at remote locations. The technology helps to deliver patient-centric care remotely to the patients thereby reducing the need for emergency department visits and reducing the rate of hospitalizations. Despite the advantages, concerns regarding cybersecurity, data privacy, and the high cost of implementation of the services are expected to restrain the growth of the market. Moreover, telehealth focuses on increasing the accessibility of basic healthcare services to patients with enhanced safety and quality.
Telehealth applications have been successful in delivering appropriate care to patients while reducing adverse events and preventing the symptoms to go unnoticed. Innovation in digital healthcare such as smart wearables, the internet of things, advanced healthcare analytics, better internet connectivity, and the rising penetration of smartphones globally are significantly shaping the growth of the industry.
Market Segmentation
By Product Type
By Delivery Mode
By End-use
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Telehealth Market
5.1. COVID-19 Landscape: Telehealth Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Telehealth Market, By Product Type
8.1. Telehealth Market, by Product Type, 2023-2032
8.1.1 Hardware
8.1.1.1. Market Revenue and Forecast (2019-2032)
8.1.2. Software
8.1.2.1. Market Revenue and Forecast (2019-2032)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 9. Global Telehealth Market, By Delivery Mode
9.1. Telehealth Market, by Delivery Mode, 2023-2032
9.1.1. On-premise
9.1.1.1. Market Revenue and Forecast (2019-2032)
9.1.2. Web-based
9.1.2.1. Market Revenue and Forecast (2019-2032)
9.1.3. Cloud-based
9.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 10. Global Telehealth Market, By End-use
10.1. Telehealth Market, by End-use, 2023-2032
10.1.1. Payers
10.1.1.1. Market Revenue and Forecast (2019-2032)
10.1.2. Providers
10.1.2.1. Market Revenue and Forecast (2019-2032)
10.1.3. Patients
10.1.3.1. Market Revenue and Forecast (2019-2032)
Chapter 11. Global Telehealth Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.1.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.1.3. Market Revenue and Forecast, by End-use (2019-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.1.4.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.1.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.1.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.1.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.2.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.2.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.2.4.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.2.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.2.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.2.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.2.6.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.2.6.3. Market Revenue and Forecast, by End-use (2019-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.2.7.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.2.7.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.3.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.3.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.3.4.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.3.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.3.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.3.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.3.6.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.3.6.3. Market Revenue and Forecast, by End-use (2019-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.3.7.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.3.7.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.4.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.4.4.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.4.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.4.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.4.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.4.6.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.4.6.3. Market Revenue and Forecast, by End-use (2019-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.4.7.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.4.7.3. Market Revenue and Forecast, by End-use (2019-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.5.3. Market Revenue and Forecast, by End-use (2019-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.5.4.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.5.4.3. Market Revenue and Forecast, by End-use (2019-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product Type (2019-2032)
11.5.5.2. Market Revenue and Forecast, by Delivery Mode (2019-2032)
11.5.5.3. Market Revenue and Forecast, by End-use (2019-2032)
Chapter 12. Company Profiles
12.1. Koninklijke Philips N.V
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Siemens Healthineers
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Cerner Corp.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. GE Healthcare
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Medtronic PLC
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Teladoc Health Inc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. American Well
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Doctor on Demand
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. GlobalMed
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. MDLive
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers